|
|
|
Volumn 12, Issue 4, 2003, Pages 36-44
|
|
Management of moderate to severe plaque psoriasis with biologic therapy.
a
a
NONE
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ALEFACEPT;
BIOLOGICAL PRODUCT;
EFALIZUMAB;
HYBRID PROTEIN;
INFLIXIMAB;
MONOCLONAL ANTIBODY;
ANTIGEN PRESENTING CELL;
BIOLOGICAL THERAPY;
CLASSIFICATION;
CLINICAL TRIAL;
DISEASE MANAGEMENT;
DRUG DELIVERY SYSTEM;
DRUG EFFECT;
HUMAN;
IMMUNOLOGY;
PATHOPHYSIOLOGY;
PSORIASIS;
REVIEW;
T LYMPHOCYTE;
UNITED STATES;
ANTIBODIES, MONOCLONAL;
ANTIGEN-PRESENTING CELLS;
BIOLOGICAL PRODUCTS;
BIOLOGICAL THERAPY;
CLINICAL TRIALS;
DISEASE MANAGEMENT;
DRUG DELIVERY SYSTEMS;
HUMANS;
PSORIASIS;
RECOMBINANT FUSION PROTEINS;
T-LYMPHOCYTES;
UNITED STATES;
|
|
EID: 0038322251
PISSN: 10623388
EISSN: None
Source Type: Journal
DOI: None Document Type: Review |
|
Times cited : (19)
|
|
References (38)
|
